| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in traumatic brain injury research in 2020
|
Sandsmark, Danielle K
|
|
|
20 |
1 |
p. 5-7
|
artikel
|
| 2 |
A museum for Cajal's Legacy
|
DeFelipe, Javier
|
|
|
20 |
1 |
p. 25
|
artikel
|
| 3 |
APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches
|
Serrano-Pozo, Alberto
|
|
|
20 |
1 |
p. 68-80
|
artikel
|
| 4 |
Are drugs for multiple sclerosis fatigue just placebos?
|
Bourdette, Dennis
|
|
|
20 |
1 |
p. 20-21
|
artikel
|
| 5 |
Bardia Nourbakhsh
|
|
|
|
20 |
1 |
p. 25
|
artikel
|
| 6 |
Correction to Lancet Neurol 2020; 19: 998–1009
|
|
|
|
20 |
1 |
p. e1
|
artikel
|
| 7 |
Dementia research in 2020: moving forward despite the COVID-19 pandemic
|
Kivipelto, Miia
|
|
|
20 |
1 |
p. 3-5
|
artikel
|
| 8 |
Epilepsy in 2020—a new dawn
|
Cross, J Helen
|
|
|
20 |
1 |
p. 8-10
|
artikel
|
| 9 |
Headache research in 2020: disrupting and improving practice
|
Goadsby, Peter J
|
|
|
20 |
1 |
p. 7-8
|
artikel
|
| 10 |
Important advances in stroke research in 2020
|
Tsivgoulis, Georgios
|
|
|
20 |
1 |
p. 2-3
|
artikel
|
| 11 |
Jacqueline Palace: a force for good in neuroimmune disorders
|
Morgan, Jules
|
|
|
20 |
1 |
p. 24
|
artikel
|
| 12 |
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study
|
Adams, David
|
|
|
20 |
1 |
p. 49-59
|
artikel
|
| 13 |
Major advances in amyotrophic lateral sclerosis in 2020
|
Hardiman, Orla
|
|
|
20 |
1 |
p. 14-15
|
artikel
|
| 14 |
Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19
|
Tan, Eng-King
|
|
|
20 |
1 |
p. 10-12
|
artikel
|
| 15 |
Multiple sclerosis in 2020: un bon cru
|
Maillart, Elisabeth
|
|
|
20 |
1 |
p. 12-13
|
artikel
|
| 16 |
Neurological infections in 2020: COVID-19 takes centre stage
|
Fredrich, Sarah
|
|
|
20 |
1 |
p. 17-18
|
artikel
|
| 17 |
New therapies for neuromyelitis optica spectrum disorder
|
Levy, Michael
|
|
|
20 |
1 |
p. 60-67
|
artikel
|
| 18 |
Oral steroids for episodic cluster headache
|
Ducros, Anne
|
|
|
20 |
1 |
p. 19-20
|
artikel
|
| 19 |
Our health-care system is failing young people with epilepsy
|
Hargreaves, Dougal
|
|
|
20 |
1 |
p. 26-27
|
artikel
|
| 20 |
Patisiran in hereditary transthyretin-mediated amyloidosis
|
Luigetti, Marco
|
|
|
20 |
1 |
p. 21-23
|
artikel
|
| 21 |
Rapid drug access and scientific rigour: a delicate balance
|
The Lancet Neurology,
|
|
|
20 |
1 |
p. 1
|
artikel
|
| 22 |
Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: a randomised, placebo-controlled, crossover, double-blind trial
|
Nourbakhsh, Bardia
|
|
|
20 |
1 |
p. 38-48
|
artikel
|
| 23 |
Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial
|
Obermann, Mark
|
|
|
20 |
1 |
p. 29-37
|
artikel
|
| 24 |
Sleep research in 2020: COVID-19-related sleep disorders
|
Partinen, Markku
|
|
|
20 |
1 |
p. 15-17
|
artikel
|
| 25 |
The STAGES of life with young onset Parkinson's disease
|
Sansom, Clare
|
|
|
20 |
1 |
p. 28
|
artikel
|
| 26 |
Turning the tables on his audience
|
Ranscombe, Peter
|
|
|
20 |
1 |
p. 27
|
artikel
|
Tijdschrift beschrijving